New Jersey’s once-in-a-lifetime – but urgent – construction opportunity

By: Chrissy Buteas, President and Chief Executive Officer, HealthCare Institute of New Jersey (HINJ) and William Mullen, President, New Jersey Building and Construction Trades Council 

October 28, 2025 | newjerseyglobe.com

New Jersey faces an unprecedented opportunity over the next few months as America’s pharmaceutical industry looks to double down on American investment by relocating overseas R&D and manufacturing facilities to various locations around the United States and expanding some of our American-based facilities.

These investments in America will mean tens (if not hundreds) of billions of dollars in construction projects, increased jobs and greater economic activity for whatever states are lucky enough – or smart enough – to attract these companies, their new facilities, and the jobs they will generate.

Some of these investments and expansions have already been announced – in North Carolina, Delaware, Texas, Indiana, Virginia . . . the list of other states gaining these investments goes on.  Except for a few expansions of existing facilities, New Jersey has barely been on the list, particularly for new facility construction.

But it’s not too late – there will be more announcements in the coming weeks and months.  New Jersey needs to act – and act urgently – to secure our state’s share of this one-in-a-lifetime opportunity construction activity boon.  It comes down to some very strong advantages versus one glaring disadvantage.

Read More: Click Here